P. Suresh Jayasekara

Statistics

Publications

Citations

291

H-Index

Active since

2012

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

University of North Carolina at Chapel Hill

P. Suresh Jayasekara is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, molecular pharmacology, and pharmacology.

Publications per year

2012–2021

Publications

A Selective High-Affinity Antagonist of the P2Y14 Receptor Inhibits UDP-Glucose–Stimulated Chemotaxis of Human Neutrophils

Matthew O. Barrett, Juliana I. Sesma, Christopher B. Ball et al. · Molecular Pharmacology · 2013 · 113 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivo

Edith Hochhauser, Ronit Cohen, Maayan Waldman et al. · Purinergic Signalling · 2013 · 38 citations · Full text

Medicine, Cardiology, Pharmacology +11

Characterization of polyamidoamino (PAMAM) dendrimers using in-line reversed phase LC electrospray ionization mass spectrometry

John R. Lloyd, P. Suresh Jayasekara, Kenneth A. Jacobson · Analytical Methods · 2015 · 32 citations

Pharmacy, Chemistry, Medicinal Chemistry +15

Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?

P. Suresh Jayasekara, Sophie Skanchy, Marlene T. Kim et al. · Regulatory Toxicology and Pharmacology · 2021 · 24 citations · Full text

Pharmacy, Toxicology, Drug Approval Processes +12

Structure-Based Design of Reactive Nucleosides for Site-Specific Modification of the A<sub>2A</sub>Adenosine Receptor

Steven M. Moss, P. Suresh Jayasekara, Silvia Paoletta et al. · ACS Medicinal Chemistry Letters · 2014 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 9